A Channel‐Dimensional Feature‐Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b‐Value Diffusion‐Weighted MRI

Xin‐Xiang Zhou,Lan Zhang,Quan‐Xiang Cui,Hui Li,Xi‐Qiao Sang,Hong‐Xia Zhang,Yue‐Min Zhu,Zi‐Xiang Kuai
DOI: https://doi.org/10.1002/jmri.28895
IF: 4.4
2023-07-06
Journal of Magnetic Resonance Imaging
Abstract:Background Dynamic contrast‐enhanced (DCE) MRI commonly outperforms diffusion‐weighted (DW) MRI in breast cancer discrimination. However, the side effects of contrast agents limit the use of DCE‐MRI, particularly in patients with chronic kidney disease. Purpose To develop a novel deep learning model to fully exploit the potential of overall b‐value DW‐MRI without the need for a contrast agent in predicting breast cancer molecular subtypes and to evaluate its performance in comparison with DCE‐MRI. Study Type Prospective. Subjects 486 female breast cancer patients (training/validation/test: 64%/16%/20%). Field Strength/Sequence 3.0 T/DW‐MRI (13 b‐values) and DCE‐MRI (one precontrast and five postcontrast phases). Assessment The breast cancers were divided into four subtypes: luminal A, luminal B, HER2+, and triple negative. A channel‐dimensional feature‐reconstructed (CDFR) deep neural network (DNN) was proposed to predict these subtypes using pathological diagnosis as the reference standard. Additionally, a non‐CDFR DNN (NCDFR‐DNN) was built for comparative purposes. A mixture ensemble DNN (ME‐DNN) integrating two CDFR‐DNNs was constructed to identify subtypes on multiparametric MRI (MP‐MRI) combing DW‐MRI and DCE‐MRI. Statistical Tests Model performance was evaluated using accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC). Model comparisons were performed using the one‐way analysis of variance with least significant difference post hoc test and the DeLong test. P
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?